Literature DB >> 25662955

Landscape of Pin1 in the cell cycle.

Cheng-Han Lin1, Hao-Yi Li1, Yu-Cheng Lee1, Marcus J Calkins1, Kuen-Haur Lee2, Chia-Ning Yang3, Pei-Jung Lu4.   

Abstract

Pin1 is a peptidyl-prolyl isomerase which plays a critical role in many diseases including cancer and Alzheimer's disease. The essential role of Pin1 is to affect stability, localization or function of phosphoproteins by catalyzing structural changes. Among the collection of Pin1 substrates, many have been shown to be involved in regulating cell cycle progression. The cell cycle disorder caused by dysregulation of these substrates is believed to be a common phenomenon in cancer. A number of recent studies have revealed possible functions of several important Pin1-binding cell cycle regulators. Investigating the involvement of Pin1 in the cell cycle may assist in the development of future cancer therapeutics. In this review, we summarize current knowledge regarding the network of Pin1 substrates and Pin1 regulators in cell cycle progression. In G1/S progression, cyclin D1, RB, p53, p27, and cyclin E are all well-known cell cycle regulators that are modulated by Pin1. During G2/M transition, our lab has shown that Aurora A suppresses Pin1 activity through phosphorylation at Ser16 and cooperates with hBora to modulate G2/M transition. We conclude that Pin1 may be thought of as a molecular timer which modulates cell cycle progression networks.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Aurora A; Pin1; cell cycle; hBora

Mesh:

Substances:

Year:  2015        PMID: 25662955      PMCID: PMC4935233          DOI: 10.1177/1535370215570829

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  48 in total

1.  Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells.

Authors:  Frank Eckerdt; Juping Yuan; Krishna Saxena; Bernd Martin; Sven Kappel; Christine Lindenau; Andrea Kramer; Steffen Naumann; Sebastian Daum; Gunter Fischer; Ivan Dikic; Manfred Kaufmann; Klaus Strebhardt
Journal:  J Biol Chem       Date:  2005-08-23       Impact factor: 5.157

2.  Hyperthermia stress activates heat shock protein expression via propyl isomerase 1 regulation with heat shock factor 1.

Authors:  Hsiu-Yu Wang; Jimmy Chun-Ming Fu; Yu-Cheng Lee; Pei-Jung Lu
Journal:  Mol Cell Biol       Date:  2013-10-14       Impact factor: 4.272

3.  Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation.

Authors:  D V Bulavin; S Saito; M C Hollander; K Sakaguchi; C W Anderson; E Appella; A J Fornace
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

4.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

5.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

Authors:  Gustavo Ayala; Dagong Wang; Gerburg Wulf; Anna Frolov; Rile Li; Janusz Sowadski; Thomas M Wheeler; Kun Ping Lu; Lere Bao
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

6.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils.

Authors:  Jiyoung Oh; James S Malter
Journal:  J Immunol       Date:  2013-04-19       Impact factor: 5.422

8.  Pin1 catalyzes conformational changes of Thr-187 in p27Kip1 and mediates its stability through a polyubiquitination process.

Authors:  Wei Zhou; Qiaoyun Yang; Choon Bing Low; Balakrishna Chandrababu Karthik; Yu Wang; Akihide Ryo; Shao Q Yao; Daiwen Yang; Yih-Cherng Liou
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

9.  The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer.

Authors:  Alessandra Rustighi; Luca Tiberi; Alessia Soldano; Marco Napoli; Paolo Nuciforo; Antonio Rosato; Fred Kaplan; Anthony Capobianco; Salvatore Pece; Pier Paolo Di Fiore; Giannino Del Sal
Journal:  Nat Cell Biol       Date:  2009-01-18       Impact factor: 28.824

10.  p53 is associated with p34cdc2 in transformed cells.

Authors:  J Milner; A Cook; J Mason
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

View more
  21 in total

Review 1.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

2.  NUP98 fusion oncoproteins interact with the APC/C(Cdc20) as a pseudosubstrate and prevent mitotic checkpoint complex binding.

Authors:  Valentina Salsi; Sebastian Fantini; Vincenzo Zappavigna
Journal:  Cell Cycle       Date:  2016-04-20       Impact factor: 4.534

3.  Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.

Authors:  Zhenzhen Zhang; Weixing Yu; Min Zheng; Xinhua Liao; Jichuang Wang; Dayun Yang; Wenxian Lu; Long Wang; Sheng Zhang; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Mol Carcinog       Date:  2019-04-26       Impact factor: 4.784

Review 4.  Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.

Authors:  Jianping Guo; Ji Cheng; Brian J North; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-07-08       Impact factor: 10.680

5.  Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.

Authors:  Giuseppe Legname; Tommaso Virgilio; Edoardo Bistaffa; Chiara Maria Giulia De Luca; Marcella Catania; Paola Zago; Elisa Isopi; Ilaria Campagnani; Fabrizio Tagliavini; Giorgio Giaccone; Fabio Moda
Journal:  Prion       Date:  2018-05-18       Impact factor: 3.931

6.  Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition.

Authors:  Man-Li Luo; Fang Zheng; Wenying Chen; Zhi-Mei Liang; Gurushankar Chandramouly; Jianan Tan; Nicholas A Willis; Chun-Hau Chen; Mateus de Oliveira Taveira; Xiao Zhen Zhou; Kun Ping Lu; Ralph Scully; Gerburg M Wulf; Hai Hu
Journal:  Cancer Res       Date:  2020-03-19       Impact factor: 12.701

7.  Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Also Exhibit Chaperone like Activity In-Vitro and In-Vivo.

Authors:  Saurabh Pandey; Ashish Sharma; Deeksha Tripathi; Ashutosh Kumar; Mohd Khubaib; Manish Bhuwan; Tapan Kumar Chaudhuri; Seyed Ehtesham Hasnain; Nasreen Zafar Ehtesham
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

8.  The Prolyl Isomerase Pin1 Promotes the Herpesvirus-Induced Phosphorylation-Dependent Disassembly of the Nuclear Lamina Required for Nucleocytoplasmic Egress.

Authors:  Jens Milbradt; Corina Hutterer; Hanife Bahsi; Sabrina Wagner; Eric Sonntag; Anselm H C Horn; Benedikt B Kaufer; Yasuko Mori; Heinrich Sticht; Torgils Fossen; Manfred Marschall
Journal:  PLoS Pathog       Date:  2016-08-24       Impact factor: 6.823

9.  Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.

Authors:  Xiaolan Lian; Yu-Min Lin; Shingo Kozono; Megan K Herbert; Xin Li; Xiaohong Yuan; Jiangrui Guo; Yafei Guo; Min Tang; Jia Lin; Yiping Huang; Bixin Wang; Chenxi Qiu; Cheng-Yu Tsai; Jane Xie; Ziang Jeff Gao; Yong Wu; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu; Yuanzhong Chen
Journal:  J Hematol Oncol       Date:  2018-05-30       Impact factor: 17.388

10.  Peptidyl-Prolyl Isomerase 1 Regulates Ca2+ Handling by Modulating Sarco(Endo)Plasmic Reticulum Calcium ATPase and Na2+/Ca2+ Exchanger 1 Protein Levels and Function.

Authors:  Veronica Sacchi; Bingyan J Wang; Dieter Kubli; Alexander S Martinez; Jung-Kang Jin; Roberto Alvarez; Nirmala Hariharan; Christopher Glembotski; Takafumi Uchida; James S Malter; Yijun Yang; Polina Gross; Chen Zhang; Steven Houser; Marcello Rota; Mark A Sussman
Journal:  J Am Heart Assoc       Date:  2017-10-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.